Chinese General Practice ›› 2020, Vol. 23 ›› Issue (5): 604-610.DOI: 10.12114/j.issn.1007-9572.2020.00.004
• Monographic Research • Previous Articles Next Articles
Published:
2020-02-15
Online:
2020-02-15
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2020.00.004
[1]HSU W L,LI S Y,LIU J S,et al.High uric acid ameliorates indoxyl sulfate-induced endothelial dysfunction and is associated with lower mortality among hemodialysis patients[J].Toxins(Basel),2017,9(1):E20.DOI:10.3390/toxins9010020. [2]马倩倩,李鸣,吴慧杰,等.血清尿酸与缺血性脑血管病的研究进展[J].中风与神经疾病杂志,2017,34(11):1036-1037.http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zfysjjbzz201711021. [3]WU J,QIU L,CHENG X Q,et al.Hyperuricemia and clustering of cardiovascular risk factors in the Chinese adult population[J].Sci Rep,2017,7(1):5456.DOI:10.1038/s41598-017-05751-w. [4]刘晓琳,顾建钧,阮晓楠,等.上海市浦东新区高尿酸血症流行状况及其危险因素研究[J].中国慢性病预防与控制,2017,25(3):165-170.DOI:10.16386/j.cjpccd.issn.1004-6194.2017.03.002. LIU X L,GU J J,RUAN X N,et al.Prevalence and risk factors of hyperuricemia in Pudong New District of Shanghai[J].Chinese Journal of Prevention and Control of Chronic Diseases,2017,25(3):165-170.DOI:10.16386/j.cjpccd.issn.1004-6194.2017.03.002. [5]周晓燕,赵琦,王娜,等.上海市松江区社区居民高尿酸血症与慢性肾病的相关性研究[J].中华疾病控制杂志,2019,23(3):278-282,293.DOI:10.16462/j.cnki.zhjbkz.2019.03.007. ZHOU X Y,ZHAO Q,WANG N,et al.Relationship between hyperuricemia and chronic kidney disease in adult residents of communities in the Songjiang District,Shanghai[J].Chinese Journal of Disease Control & Prevention,2019,23(3):278-282,293.DOI:10.16462/j.cnki.zhjbkz.2019.03.007. [6]张容,何庆莉,杨小红.重庆市健康体检人群高尿酸血症与多代谢异常检出现况及其相关性研究[J].成都医学院学报,2019,14(1):110-114.DOI:10.3969/j.issn.1674-2257.2019.01.026. ZHANG R,HE Q L,YANG X H.A study on the prevalence of hyperuricemia and multiple metabolic disorders and their correlation among the physical examination population in Chongqing[J].Journal of Chengdu Medical College,2019,14(1):110-114.DOI:10.3969/j.issn.1674-2257.2019.01.026. [7]CHENG D,DU R,WU X Y,et al.Serum uric acid is associated with the predicted risk of prevalent cardiovascular disease in a community-dwelling population without diabetes[J].Biomed Environ Sci,2018,31(2):106-114.DOI:10.3967/bes2018.013. [8]魏若妍,张源,张复亮,等.上海市徐家汇街道老年人高尿酸血症、痛风患病状况及影响因素研究[J].中国全科医学,2019,22(16):1954-1959,1972. WEI R Y,ZHANG Y,ZHANG F L,et al.Prevalence and associated factors of hyperuricemia and gout in elderly people in Xujiahui Subdistrict,Shanghai[J].Chinese General Practice,2019,22(16):1954-1959,1972. [9]杨欣丽,王惠君.成人中心型肥胖的流行趋势及其影响因素[J].中国健康教育,2014,30(7):634-636.DOI:10.16168/j.cnki.issn.1002-9982.2014.07.018. YANG X L,WANG H J.The prevalence and influence factors of central obesity in adults[J].Chinese Journal of Health Education,2014,30(7):634-636.DOI:10.16168/j.cnki.issn.1002-9982.2014.07.018. [10]中华医学会内分泌学分会.中国成人2型糖尿病HbA1c控制目标的专家共识[J].中华内分泌代谢杂志,2011,27(5):371-374.DOI:10.3760/cma.j.issn.1000-6699.2011.05.003. Chinese Society of Endocrinology.Expert consensus of HbA1c control target for Chineses adult with type 2 diabetes[J].Chinese Journal of Endocrinology and Metabolism,2011,27(5):371-374.DOI:10.3760/cma.j.issn.1000-6699.2011.05.003. [11]张秀梅,马丹娜,鄂静,等.慢性肾脏病患者血尿酸水平变化及影响因素[J].宁夏医学杂志,2019,41(4):335-337.DOI:10.13621/j.1001-5949.2019.04.0335.http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=nxyxzz201904018. [12]中华医学会内分泌学分会.中国成人糖尿病肾脏病临床诊断的专家共识[J].中华内分泌代谢杂志,2015,31(5):379-385.DOI:10.3760/cma.j.issn.1000-6699.2015.05.001.http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhnfmdx201505001. [13]高尿酸血症相关疾病诊疗多学科共识专家组.中国高尿酸血症相关疾病诊疗多学科专家共识[J].中华内科杂志,2017,56(3):235-248.DOI:10.3760/cma.j.issn.0578-1426.2017.03.021. Multi-Disciplinary Expert Task Force on Hyperurice.Chinese multi-disciplinary consensus on the diagnosis and treatment of hyperuricemia and its related diseases[J].Chinese Journal of Internal Medicine,2017,56(3):235-248.DOI:10.3760/cma.j.issn.0578-1426.2017.03.021. [14]国务院人口普查办公室.中国2010年人口普查资料[EB/OL].[2019-6-15].http://www.stats.gov.cn/tjtj/pcsj/rkpc/6rp/indexch.htm. [15]褚爱群,郑琳,岑惠忠,等.上海市金山石化地区老年人高尿酸血症患病情况及相关因素分析[J].上海预防医学,2019,31(3):183-187. CHU A Q,ZHENG L,CEN H Z,et al.Prevalence and related factor analysis on hyperuricemia in elderly in Jinshan District,Shanghai[J].Shanghai Journal of Preventive Medicine,2019,31(3):183-187. [16]刘胜峰,潘效营,赖华娟.上海某社区老年人群高尿酸血症患病率及危险因素分析[J].社区医学杂志,2017,15(17):1-3. LIU S F,PAN X Y,LAI H J.Prevalence and risk factors of hyperuricemia among elderly population in a community of Shanghai[J].Journal of Community Medicine,2017,15(17):1-3. [17]王宏儒,鲍晓荣.上海市社区老年人高尿酸血症及相关危险因素调查分析[J].中国中西医结合肾病杂志,2017,18(10):869-872.DOI:10.3969/j.issn.1009-587X.2017.10.008. WANG H R,BAO X R.Morbidity and risk factors of hyperuricemia in elderly people from a Shanghai community[J].Chinese Journal of Integrated Traditional and Western Nephrology,2017,18(10):869-872.DOI:10.3969/j.issn.1009-587X.2017.10.008. [18]林细明,邹蓉,李协,等.增城市荔城农村老年高尿酸血症现况及危险因素分析[J].中国医药导报,2014,11(11):101-104. LIN X M,ZOU R,LI X,et al.Prevalence survey and risk factors of hyperuricemia for rural elderly people of Licheng Street in Zengcheng City[J].China Medical Herald,2014,11(11):101-104. [19]ZHANG S S,WANG Y,CHENG J S,et al.Hyperuricemia and cardiovascular disease[J].Curr Pharm Des,2019,25(6):700-709.DOI:10.2174/1381612825666190408122557. [20]周庆锋,黄志碧,江仕清,等.代谢体检人群高尿酸血症的发生情况及其危险因素[J].广西医学,2019,41(2):225-228.DOI:10.11675/j.issn.0253-4304.2019.02.20. ZHOU Q F,HUANG Z B,JIANG S Q,et al.Occurrence and risk factors of hyperuricemia in individuals undergoing metabolic physical examination[J].Guangxi Medical Journal,2019,41(2):225-228.DOI:10.11675/j.issn.0253-4304.2019.02.20. [21]XU X L,HU J C,SONG N N,et al.Hyperuricemia increases the risk of acute kidney injury:a systematic review and meta-analysis[J].BMC Nephrol,2017,18(1):27.DOI:10.1186/s12882-016-0433-1. [22]周晓燕,赵琦,王娜,等.上海市松江区某社区成年人慢性肾病流行现况调查[J].中华流行病学杂志,2018,39(12):1555-1559.DOI:10.3760/cma.j.issn.0254-6450.2018.12.004. ZHOU X Y,ZHAO Q,WANG N,et al.Epidemiological features of adult chronic kidney diseases in a community-based population in Songjiang District,Shanghai[J].Chinese Journal of Epidemiology,2018,39(12):1555-1559.DOI:10.3760/cma.j.issn.0254-6450.2018.12.004. [23]范美娟,邓美玉,徐会,等.2型糖尿病患者高尿酸血症流行状况与相关因素研究[J].中国糖尿病杂志,2018,26(12):1013-1016.DOI:10.3969/j.issn.1006-6187.2018.12.010. FAN M J,DENG M Y,XU H,et al.Study on prevalence and correlates of hyperuricemia in type 2 diabetic patients[J].Chinese Journal of Diabetes,2018,26(12):1013-1016.DOI:10.3969/j.issn.1006-6187.2018.12.010. [24]NAKANISHI N,YOSHIDA H,NAKAMURA K,et al.Predictors for development of hyperuricemia:an 8-year longitudinal study in middle-aged Japanese men[J].Metab Clin Exp,2001,50(6):621-626.DOI:10.1053/meta.2001.24196. [25]GARCíA-ESCOBAR E,PéREZ-VALERO V,MASEDA D,et al.Glycosylated hemoglobin as a hyperuricemia risk marker in general population[J].Med Clin(Barc),2011,136(11):465-470.DOI:10.1016/j.medcli.2010.09.044. [26]CHEN S,GUO X F,YU S S,et al.Association between serum uric acid and elevated alanine aminotransferase in the general population[J].Int J Environ Res Public Health,2016,13(9):E841.DOI:10.3390/ijerph13090841. [27]TSENG W C,CHEN Y T,OU S M,et al.U-shaped association between serum uric acid levels with cardiovascular and all-cause mortality in the elderly:the role of malnourishment[J].J Am Heart Assoc,2018,7(4):e007523.DOI:10.1161/JAHA.117.007523. [28]余燕飞,王敬丽,陈利群.社区老年人高尿酸血症相关知识的调查及分析[J].中国初级卫生保健,2019,33(4):18-21.DOI:10.3969/j.issn.1001-568X.2019.04.0007. YU Y F,WANG J L,CHEN L Q.The investigation and analysis on hyperuricemia related knowledge among the elderly in community[J].Chinese Primary Health Care,2019,33(4):18-21.DOI:10.3969/j.issn.1001-568X.2019.04.0007. [29]张昀,曾学军,徐娜,等.高尿酸血症社区管理流程的专家建议[J].中华全科医师杂志,2018,17(11):878-883.DOI:10.3760/cma.j.issn.1671-7368.2018.11.004. ZHANG Y,ZENG X J,XU N,et al.Expert consensus on community-based management protocol for hyperuricemia[J].Chinese Journal of General Practitioners,2018,17(11):878-883.DOI:10.3760/cma.j.issn.1671-7368.2018.11.004. |
[1] | XU Jialan, YAN Hong, WEN Jun, ZHOU Zitong, WANG Siyu. Prevalence of Potentially Inappropriate Medication in Older Adults with Cancer: a Meta-analysis [J]. Chinese General Practice, 2025, 28(30): 3815-3822. |
[2] | LI Ling, LI Yaping, QIAN Shixing, NIE Jing, LU Chunhua, LI Xia. Research on Influencing Factors and Risk Prediction of Cognitive Function in Community-dwelling Middle-aged and Elderly People [J]. Chinese General Practice, 2025, 28(30): 3773-3778. |
[3] | ZHOU Penglong, CHANG Jing, DING Suying, CHEN Jingfeng, WANG Tao, LI Chenyang. Correlation Analysis between Age-Stratified Differences in Fat-to-muscle Ratio and Hyperuricemia [J]. Chinese General Practice, 2025, 28(27): 3375-3384. |
[4] | HU Jieman, TAN Feixiang, YUAN Anxin, CHEN Shiyu, TANG Chulei, YIN Yueheng, BA Lei, XU Qin. Analysis of the Trajectory of Postoperative Frailty and Influencing Factors in Patients with Colorectal Cancer [J]. Chinese General Practice, 2025, 28(26): 3276-3282. |
[5] | CHOU Xintong, PENG Hanyu, MA Hui, ZHANG Zhen, SU Xian, QIU Hongyan. Maternal Preferences in Contraceptive Decision-making: an Analysis of Influencing Factors [J]. Chinese General Practice, 2025, 28(26): 3294-3299. |
[6] | WEI Jiaohua, PENG Huiru, PENG Jianye, TAN Wenting, HUANG Jine, FANG Li. Expression of the Serum MOTS-c and Its Correlation with Atrial Remodeling in Patients with Atrial Fibrillation [J]. Chinese General Practice, 2025, 28(26): 3271-3276. |
[7] | LUO Xinyu, LIU Jin, CHEN Hailong. Trend Analysis of the Changing Disease Burden of Pancreatitis in China and Worldwide from 1990 to 2021 and Prediction for 2022 to 2031 [J]. Chinese General Practice, 2025, 28(26): 3321-3327. |
[8] | YU Zizi, LIU Duli, LI Ximin, RUAN Chunyi, YIN Xiangyang, CAI Le. Analysis of the Prevalence and Self-management of Hypertension and Its Influencing Factors in Rural [J]. Chinese General Practice, 2025, 28(25): 3137-3143. |
[9] | FAN Boyang, ZHANG Yu, SUN Wenning, ZHANG Huifang, WANG Yingjie, ZHANG Ao, ZHAO Yang, WANG Haipeng. Study of Behavioral Intention and Influencing Factors of Integrated Medical and Preventive Care Provided by Grassroots Doctors for Patients with Chronic Diseases [J]. Chinese General Practice, 2025, 28(25): 3144-3150. |
[10] | YU Wenhua, LI Jianguo, DUAN Wenyan, GAO Xuyan, LI Xiaxia, ZHANG Zilong, ZHANG Li, MA Lina. Reliability and Validity of the Function Impairment Screening Tool among Community-dwelling Older Adults [J]. Chinese General Practice, 2025, 28(24): 3000-3004. |
[11] | YANG Chen, CHEN Tong, ZHANG Lifang, ZHANG Hongxu, LI Pengfei, ZHANG Xuejuan. Prognostic Impact of Dapagliflozin in Elderly Breast Cancer Survivors with Heart Failure with Preserved Ejection Fraction and Type 2 Diabetes [J]. Chinese General Practice, 2025, 28(24): 3053-3058. |
[12] | WANG Rupeng, NAN Jing, HU Yiran, YANG Shenghua, JIN Zening. Predictive Value of the Triglyceride-Glucose Body Mass Index for Slow Flow/No-reflow Phenomenon in Patients with Type 2 Diabetes Mellitus and Acute Myocardial Infarction Undergoing Emergency Percutaneous Coronary Intervention [J]. Chinese General Practice, 2025, 28(24): 2985-2992. |
[13] | LI Jiaxin, LIU Zhonghui, XIE Shuo, FU Zhifang, SUN Dan, JIAO Hongmei. Trajectory in Biomarkers of Metabolic and Inflammatory States as Early Predictors of Chronic Critical Illness in Aging Patients [J]. Chinese General Practice, 2025, 28(24): 2993-2999. |
[14] | JIANG Shihua, ZHU Zheng, REN Yingying, ZHU Yaolei, WANG Yue, GAO Xibin. Meta Analysis of the Prevalence and Risk Factors of Myopia in Chinese Children and Adolescents [J]. Chinese General Practice, 2025, 28(24): 3043-3052. |
[15] | WU Yue, WANG Xuetong, KE Bilian. Evaluation of Vision-related Quality of Life in Myopic Macular Degeneration Patients with Low Vision and Associated Factors [J]. Chinese General Practice, 2025, 28(23): 2908-2914. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||